PATENT CLAIM ANALYSIS

Application Number: 16243301
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["546", "113000"]

Abstract:
Provided are certain fused tricyclic urea compounds and salts thereof, compositions thereof, and methods of use therefor.

Claim (Index 37):
A method for treating or preventing cancer selected from the group consisting of melanomas and thyroid cancer, Barret's adenocarcinoma, breast cancer, cervical cancer, colorectal cancer, gastric cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, hematologic cancers, cancer of Billary Tract, Non-small-cell-lung cancer, endometrium cancer, blood cancer, large intestinal colon carcinoma, histiocytic lymphoma, lung adenocarcinoma, comprising administrating to a subject in need thereof pharmaceutically-effective amount of at least one compound of any one of  claims 1 - 6 , stereoisomers thereof, and pharmaceutically accept salts thereof.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.17647
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15882067', '14901634', '14901556', '14369379', '15882064']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8251396308435817
- 35 USC 102 Novelty (BERT): 0.5765654294402253
- Combined Prediction Score: 0.8002822107032461
- Mean Citation Score: 493.518814
- Max Citation Score: 517.0235
- Similarity Product: 403.4750509489775

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test